{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:09:52Z","timestamp":1794586192653,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04105-3","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T11:31:49Z","timestamp":1743852709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Twice against thrice-weekly hemodialysis (TATH): a multicenter nonrandomized trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9893-5514","authenticated-orcid":false,"given":"Mabel","family":"Aoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Finianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadia","family":"Beaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Sleilaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ghaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Nourie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Kais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph El","family":"Hajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachad","family":"Alameddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Boueri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balsam El","family":"Ghoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Zeidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Dfouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Hawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Mechref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Chelala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"10041","key":"4105_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(16)30448-2","volume":"388","author":"BM Robinson","year":"2016","unstructured":"Robinson BM, Akizawa T, Jager KJ, et al. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388(10041):294\u2013306.","journal-title":"Lancet"},{"key":"4105_CR2","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.2215\/CJN.04000609","volume":"4","author":"N Lameire","year":"2009","unstructured":"Lameire N, Van Vanholder BW. Did 20 years of technological innovations in Hemodialysis contribute to better patient outcomes?? Clin J Am Soc Nephrol. 2009;4:S30\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4105_CR3","doi-asserted-by":"publisher","unstructured":"Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LY, Daugirdas JT. Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol. 1999;19(6):625\u2013\u200933. https:\/\/doi.org\/10.1159\/000013533. PMID: 10592355.","DOI":"10.1159\/000013533"},{"issue":"3","key":"4105_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000441809","volume":"1","author":"MV Rocco","year":"2015","unstructured":"Rocco MV. Chronic Hemodialysis therapy in the West. Kidney Dis (Basel). 2015;1(3):178\u201386.","journal-title":"Kidney Dis (Basel)"},{"issue":"Suppl 2","key":"4105_CR5","first-page":"ii5","volume":"22","author":"J Tattersall","year":"2007","unstructured":"Tattersall J, Martin-Malo A, Pedrini L, et al. EBPG guideline on Dialysis strategies. Nephrol Dial Transpl. 2007;22(Suppl 2):ii5\u201321.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"4105_CR6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","volume":"66","author":"National Kidney Foundation","year":"2015","unstructured":"National Kidney Foundation. KDOQI clinical practice guideline for Hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884\u2013930.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4105_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/sdi.12588","volume":"30","author":"Y Yan","year":"2017","unstructured":"Yan Y, Ramirez S, Anand S, Qian J, Zuo L. Twice-Weekly Hemodialysis in China: can it be A better option for initiation or maintenance Dialysis therapy?? Semin Dial. 2017;30(3):277\u201381.","journal-title":"Semin Dial"},{"issue":"8","key":"4105_CR8","first-page":"516","volume":"46","author":"A Stankuviene","year":"2010","unstructured":"Stankuviene A, Ziginskiene E, Kuzminskis V, Bumblyte IA. Impact of Hemodialysis dose and frequency on survival of patients on chronic Hemodialysis in Lithuania during 1998\u20132005. Med (Kaunas). 2010;46(8):516\u201321.","journal-title":"Med (Kaunas)"},{"issue":"2","key":"4105_CR9","first-page":"81","volume":"5","author":"S Elamin","year":"2012","unstructured":"Elamin S, Abu-Aisha H. Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly Hemodialysis. Arab J Nephrol Transpl. 2012;5(2):81\u20136.","journal-title":"Arab J Nephrol Transpl"},{"issue":"7","key":"4105_CR10","doi-asserted-by":"publisher","first-page":"e2767","DOI":"10.1097\/MD.0000000000002767","volume":"95","author":"HS Hwang","year":"2016","unstructured":"Hwang HS, Hong YA, Yoon HE, et al. Comparison of clinical outcome between Twice-Weekly and Thrice-Weekly Hemodialysis in patients with residual kidney function. Med (Baltim). 2016;95(7):e2767. https:\/\/doi.org\/10.1097\/MD.0000000000002767.","journal-title":"Med (Baltim)"},{"issue":"2","key":"4105_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/j.ajkd.2016.01.008","volume":"68","author":"Y Obi","year":"2016","unstructured":"Obi Y, Streja E, Rhee CM, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident Dialysis patients: A cohort study. Am J Kidney Dis. 2016;68(2):256\u201365. https:\/\/doi.org\/10.1053\/j.ajkd.2016.01.008.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4105_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.kint.2016.02.037","volume":"90","author":"AT Mathew","year":"2016","unstructured":"Mathew AT, Fishbane S, Obi Y, Kalantar-Zadeh K. Preservation of residual kidney function in Hemodialysis patients: reviving an old concept. Kidney Int. 2016;90(2):262\u201371. https:\/\/doi.org\/10.1016\/j.kint.2016.02.037.","journal-title":"Kidney Int"},{"issue":"4","key":"4105_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000441577","volume":"40","author":"Y Obi","year":"2015","unstructured":"Obi Y, Eriguchi R, Ou SM, Rhee CM, Kalantar-Zadeh K. What is known and unknown about twice-weekly Hemodialysis. Blood Purif. 2015;40(4):298\u2013305.","journal-title":"Blood Purif"},{"issue":"3","key":"4105_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/0971-4065.202844","volume":"27","author":"T Mukherjee","year":"2017","unstructured":"Mukherjee T, Devi G, Geetha S, Anchan NJ, Sankarasubbaiyan S. A comparison of practice pattern and outcome of Twice-weekly and Thrice-weekly Hemodialysis patients. Indian J Nephrol. 2017;27(3):185\u20139.","journal-title":"Indian J Nephrol"},{"issue":"2","key":"4105_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.26719\/emhj.18.032","volume":"25","author":"M Aoun","year":"2019","unstructured":"Aoun M, Makkouk J, Ammar W. Ultrapure water in haemodialysis: a step towards better quality in Lebanon. East Mediterr Health J. 2019;25(2):134\u201341. https:\/\/doi.org\/10.26719\/emhj.18.032. Published 2019 Mar 19.","journal-title":"East Mediterr Health J"},{"issue":"9","key":"4105_CR16","doi-asserted-by":"publisher","first-page":"e1308","DOI":"10.34067\/KID.0000000000000207","volume":"4","author":"M Aoun","year":"2023","unstructured":"Aoun M, Koubar S. Global Dialysis perspective: Lebanon. Kidney360. 2023;4(9):e1308\u201313. https:\/\/doi.org\/10.34067\/KID.0000000000000207.","journal-title":"Kidney360"},{"issue":"4","key":"4105_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/hdi.13045","volume":"26","author":"D Moorman","year":"2022","unstructured":"Moorman D, Pilkey NG, Goss CJ, et al. Twice versus thrice weekly hemodialysis: A systematic review. Hemodial Int. 2022;26(4):461\u201379. https:\/\/doi.org\/10.1111\/hdi.13045.","journal-title":"Hemodial Int"},{"issue":"5","key":"4105_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1053\/j.ajkd.2016.12.006","volume":"69","author":"MS Makar","year":"2017","unstructured":"Makar MS, Pun PH. Sudden cardiac death among Hemodialysis patients. Am J Kidney Dis. 2017;69(5):684\u201395. https:\/\/doi.org\/10.1053\/j.ajkd.2016.12.006. Epub 2017 Feb 17. PMID: 28223004; PMCID: PMC5457912.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"4105_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2215\/CJN.08850811","volume":"7","author":"M Jadoul","year":"2012","unstructured":"Jadoul M, Thumma J, Fuller DS, et al. Modifiable practices associated with sudden death among Hemodialysis patients in the Dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol. 2012;7(5):765\u201374. https:\/\/doi.org\/10.2215\/CJN.08850811.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"4105_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/sdi.12701","volume":"31","author":"AT Mathew","year":"2018","unstructured":"Mathew AT, Obi Y, Rhee CM, Chou JA, Kalantar-Zadeh K. Incremental Dialysis for preserving residual kidney function-Does one size fit all when initiating Dialysis? Semin Dial. 2018;31(4):343\u201352. https:\/\/doi.org\/10.1111\/sdi.12701.","journal-title":"Semin Dial"},{"issue":"3","key":"4105_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.kint.2021.07.025","volume":"101","author":"E Vilar","year":"2022","unstructured":"Vilar E, Kaja Kamal RM, Fotheringham J, et al. A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of Hemodialysis on residual kidney function. Kidney Int. 2022;101(3):615\u201325. https:\/\/doi.org\/10.1016\/j.kint.2021.07.025.","journal-title":"Kidney Int"},{"issue":"2","key":"4105_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/j.ajkd.2021.12.001","volume":"80","author":"M Murea","year":"2022","unstructured":"Murea M, Patel A, Highland BR, et al. Twice-Weekly Hemodialysis with adjuvant pharmacotherapy and transition to Thrice-Weekly hemodialysis: A pilot study. Am J Kidney Dis. 2022;80(2):227\u2013e2401. https:\/\/doi.org\/10.1053\/j.ajkd.2021.12.001.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4105_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/ndt\/gfac274","volume":"38","author":"E Caton","year":"2023","unstructured":"Caton E, Sharma S, Vilar E, Farrington K. Impact of incremental initiation of haemodialysis on mortality: a systematic review and meta-analysis. Nephrol Dial Transpl. 2023;38(2):435\u201346. https:\/\/doi.org\/10.1093\/ndt\/gfac274. PMID: 36130107; PMCID: PMC9923704.","journal-title":"Nephrol Dial Transpl"},{"key":"4105_CR24","doi-asserted-by":"crossref","unstructured":"Takkavatakarn K, Jintanapramote K, Phannajit J, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P. Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis. Clin Kidney J. 2023;17(1).","DOI":"10.1093\/ckj\/sfad280"},{"issue":"1","key":"4105_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2215\/CJN.04170320","volume":"16","author":"M Murea","year":"2020","unstructured":"Murea M, Kalantar-Zadeh K. Incremental and Twice-Weekly Hemodialysis program in practice. Clin J Am Soc Nephrol. 2020;16(1):147\u20139. https:\/\/doi.org\/10.2215\/CJN.04170320.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"4105_CR26","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.ekir.2022.02.010","volume":"7","author":"M Torreggiani","year":"2022","unstructured":"Torreggiani M, Fois A, Chatrenet A, et al. Incremental and personalized Hemodialysis start: A new standard of care. Kidney Int Rep. 2022;7(5):1049\u201361. https:\/\/doi.org\/10.1016\/j.ekir.2022.02.010. Published 2022 Feb 19.","journal-title":"Kidney Int Rep"},{"key":"4105_CR27","doi-asserted-by":"publisher","unstructured":"Chan CT, Blankestijn PJ, Dember LM et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;96(1):37\u201347. https:\/\/doi.org\/10.1016\/j.kint.2019.01.017","DOI":"10.1016\/j.kint.2019.01.017"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04105-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04105-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04105-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T11:32:09Z","timestamp":1743852729000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04105-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4105"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04105-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Hotel Dieu de France\/Saint-Joseph University (CEHDF 1114) and was conducted in agreement with the Helsinki Declaration of 1975. All included patients gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients gave their consent for results\u2019 dissemination.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The trial was registered on ClinicalTrials.gov (Identifier NCT03415776) on January 16, 2018.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study registration"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}